Literature DB >> 18398101

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

Bette Caan, Laurel Habel, Charles Quesenberry, Larry Kushi, Lisa Herrinton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18398101     DOI： 10.1093/jnci/djn079

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

2.  Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use?

Authors:  Nancy Breen; Kathleen A Cronin; Jasmin A Tiro; Helen I Meissner; Timothy S McNeel; Susan A Sabatino; Florence K Tangka; Stephen H Taplin
Journal:  Cancer       Date:  2011-08-22       Impact factor: 6.860

3.  The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Patrick L Remington
Journal:  Cancer Causes Control       Date:  2010-11-16       Impact factor: 2.506

4.  Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status.

Authors:  Amelia K Hausauer; Theresa H M Keegan; Ellen T Chang; Sally L Glaser; Holly Howe; Christina A Clarke
Journal:  BMC Med       Date:  2009-06-26       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.